MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with ...

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

An international expert panel has developed consensus guidelines to help clinicians navigate multiple sclerosis (MS) diagnosis in atypical populations — specifically children and older adults. Here's ...

Glenn Wylie, DPhil is director of the Rocco Ortenzio Neuroimaging Center and recipient of a National Multiple Sclerosis Society grant. East Hanover, NJ — April 9, 2024 —The National Multiple Sclerosis ...

The biggest difference between ocrelizumab and the recently approved ofatumumab is that ofatumumab can be taken at home for relapsing forms of multiple sclerosis (MS), explained Patricia K. Coyle, MD.

Pain may be an early symptom of MS, with increased gabapentinoid and anticonvulsant prescriptions seen in the years before disease onset. Patients with MS showed higher odds of filling prescriptions ...

Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately ...